The current opioid epidemic has touched nearly every facet of American society. Opioids are entering our homes in a conventional manner and harming our loved ones in unconventional ways. In 2015, a staggering 52,404 deaths by overdose were reported, making drug overdose the leading cause of accidental death in the United States. Bizzell is devoted to making a positive change in the opioid crisis by using its 20 plus years of subject matter expertise to support and provide prevention, treatment, and recovery strategies and services aimed at reducing and eliminating opioid use disorders and its effects on our nation. Our team of public health experts—seasoned physicians, pharmacists, public health specialists, and educators—has developed a comprehensive approach to minimize the impact of opioid use disorders in our communities.

Our Services

Our Capabilities

The Bizzell staff is committed to providing solutions to address the current opioid epidemic. We will continue to lead efforts to address substance use disorders and prevent overdoses by engaging providers and first responders through education. Our subject matter experts have developed innovative prevention and treatment models, and strategies for addressing barriers to preventing and treating substance use disorders. Bizzell provides comprehensive and innovative services for providers and clients that encourage appropriate use of prescription medications and discourage misuse, abuse, and overdose. Our services include:

  • Serving as a central source of evidence-based information on the therapeutic and non-therapeutic uses of prescription drugs

  • Serving as a national resource for information on effective programs, which encourage appropriate prescription drug use and discourage misuse, abuse, and overdose

  • Engaging provider communities to develop and adopt useful clinical tools and guidelines on risk factors that affect diagnosis and treatment of emerging or overt problems

  • Providing ongoing education on substance use disorders and treatment to administrators and health alliances within elementary, secondary, and post-secondary school systems

  • Providing naloxone trainings to community members to empower first responders, families, and friends of individuals at risk for overdose

  • Educating law enforcement communities, patient advocates, and practitioners about substance use disorders

Bizzell understands that this problem is complex and affects each demographic uniquely. Our subject matter experts aim to reduce the effect of opioid use disorders on adolescents and young adults, women and children, the elderly population, and those who live in rural areas.

Project Highlights

SAFE PAIN AND COMPETENT OPIOID EDUCATION
Prescriber Education and Technical Assistance

Bizzell, as a teammate of Boston University, assists the FDA Risk Evaluation and Mitigation Strategies (REMS) grant by providing logistics for trainings throughout the United States, for which attendees can earn professional development hours. The FDA has mandated manufacturers of extended-release/long-acting (ER/ LA) opioid analgesics to make available comprehensive prescriber education in the safe use of these medications, based on the FDA curriculum known as the Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid (ER/LA) Analgesics. To provide a comprehensive educational program, our curriculum covers all aspects of this blueprint and more.

OPIOID TREATMENT PROGRAM QUALITY
Opioid Technical Assistance and Provider Education

Bizzell supports SAMHSA in the administration of OTP–Q. The focus of this project is to help opioid treatment programs (OTPs) and state agencies identify any changes needed to meet accreditation standards and give them the resources to make those changes. Bizzell provides technical assistance to more than 1,400 opioid treatment programs, provider groups, and state systems responsible for developing policy and programming for medically assisted treatment. The project is also responsible for providing medical education to clinical professionals, including medical directors, nurses, physician assistants, and clinical supervisors working with individuals addicted to opiates. The Opioid Treatment Program–Quality (OTP–Q) contract is funded through the SAMHSA’s Division of Pharmacologic Therapies.

MEDICATION ASSISTED TREATMENT – PRESCRIPTION DRUG AND OPIOID ABUSE
Policy Stakeholder Meetings

Bizzell provides support services to SAMHSA’s MATPDOA Targeted Capacity Expansion efforts by planning, hosting, and supporting eleven policy stakeholder meetings. These meetings convene state and local leaders to identify current funding policies that impact MAT, and particularly focus on Medicaid programs with clinically-sound and cost-effective delivery and financing approaches for providing these medications, behavioral therapies, and recovery support services. The objectives of these SAMHSA-sponsored meetings are to review current state-by-state Medicaid coverage of MAT for opioid use disorders, to identify innovative financing and delivery models for MAT using state case studies, and to refine proposed activities to ensure sustainable outcomes.

ADDRESSING OPIOID-RELATED MISUSE AND OVERDOSE
Research Analysis Coordination

For the Center for Substance Abuse Treatment (CSAT) Addressing Opioid-Related Misuse and Overdose contract, Bizzell builds on Substance Abuse and Mental Health Services Administration’s (SAMHSA) previous workforce competency efforts for pain management and addiction professionals by developing and implementing multifaceted initiatives and strategies to address opioid use disorder and related conditions. Specifically, these initiatives and strategies focus on utilizing research, assessment, education, and training to:

  • Build infrastructure that ensures the availability of qualified healthcare professionals capable of meeting the challenges of opioid use disorder and other emerging issues
  • Disseminate new medical, clinical, and technological interventions to address substance misuse

MEDICATION-ASSISTED TREATMENT
Prescription Drug and Opioid Abuse Technical Assistance

Bizzell provides technical assistance and training to SAMHSA’s programs and divisions in the areas of substance use disorders and behavioral health in order to support successful program implementation and enhance program outcomes. Technical assistance and training needs are identified by strategic priorities and objectives or programmatic goals, needs assessments, grantee requests, or requests from states, tribal organizations, communities, schools/colleges/universities, and individuals. SAMHSA’s strategic initiatives address trauma; support military families; improve access to culturally competent, high-quality care; develop community, peer, and family support; build information systems; and promote important messages about behavioral health.

Our clients drive real-world change. We accelerate it. We meet complex challenges with comprehensive, innovative solutions. We are prepared to meet your greatest challenges and develop strategies that meet your impact goals.

Contact Now